DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase):: Association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients

被引:0
|
作者
Romain, S
Bendahl, PO
Guirou, O
Malmström, P
Martin, PM
Fernö, M
机构
[1] Fac Med Nord, Lab Trasnfert Oncol Biol, AP HM, F-13916 Marseille 20, France
[2] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
关键词
D O I
10.1002/1097-0215(20010120)95:1<56::AID-IJC1010>3.0.CO;2-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
S-phase fraction (SPF) is a reference for cell-kinetic analysis. In this study, the links between SPF and the essential enzymes participating in the pyrimidine synthesis were investigated in breast cancer and their relationships with the natural history of the disease were compared. We measured thymidine kinase (TK) for salvage synthesis, thymidylate synthase (TS) for de novo synthesis and thymidylate kinase (TMK), which is required for both pathways. Our study population consisted of 211 premenopausal women with node-negative tumors, SPF was assessed prospectively by flow cytometry, whereas enzyme activities were measured retrospectively in cytosols using radioenzymatic methods, Among the enzymes analyzed, only TK demonstrated a strong correlation with SPF (r(s) = 0.59), In univariate analysis, high SPF and high levels of TK were associated with increased risk of developing distant recurrences (p < 0.001). Correlations with other prognostic factors (histological grade, steroid receptors, DNA ploidy status, urokinase plasminogen activator and plasminogen activator inhibitor type I)confirmed a parallel association of SPF and TK with the most aggressive tumors. In contrast, TS and TMK were not associated with prognosis, After adjustment for SPF, the risk of relapse increased significantly with TK values. Subgroup analysis showed that additional information was provided by TK in the tumors with low SPF, When urokinase plasminogen activator (uPA) was a candidate variable in multivariate analysis, TK remained significant, Combined with SPF and uPA, TK could be useful to define premenopausal node-negative patients with rapidly proliferating tumors at a high risk of metastatic disease. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 24 条
  • [1] Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens
    Bagwell, CB
    Clark, GM
    Spyratos, F
    Chassevent, A
    Bendahl, PO
    Stål, O
    Killander, D
    Jourdan, ML
    Romain, S
    Hunsberger, B
    Baldetorp, B
    CYTOMETRY, 2001, 46 (03): : 121 - 135
  • [2] CYTOMETRIC-FLOW MEASURED S-PHASE FRACTION AND PLOIDY AS PROGNOSTIC FACTORS IN PRIMARY NODE-NEGATIVE BREAST-CANCER
    WINTER, K
    EIDTMANN, H
    JONAT, W
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1994, 54 (05) : 291 - 294
  • [3] Histological grade, its three components, and flow cytometric S-phase as prognostic markers in premenopausal women with node-negative breast cancer.
    Malmström, P
    Elston, CW
    Bendahl, PO
    Boiesen, P
    Fernö, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 263 - 263
  • [4] Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis
    Peiro, G
    Lerma, E
    Climent, MA
    Segui, MA
    Alonso, MC
    Prat, J
    MODERN PATHOLOGY, 1997, 10 (03) : 216 - 222
  • [5] PROGNOSTIC-SIGNIFICANCE OF S-PHASE FRACTION IN GOOD-RISK, NODE-NEGATIVE BREAST-CANCER PATIENTS
    CLARK, GM
    MATHIEU, MC
    OWENS, MA
    DRESSLER, LG
    EUDEY, L
    TORMEY, DC
    OSBORNE, CK
    GILCHRIST, KW
    MANSOUR, EG
    ABELOFF, MD
    MCGUIRE, WL
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) : 428 - 432
  • [6] PROGNOSTIC-SIGNIFICANCE OF FLOW CYTOMETRIC DNA ANALYSIS IN NODE-NEGATIVE BREAST-CANCER PATIENTS
    LEWIS, WE
    CANCER, 1990, 65 (10) : 2315 - 2320
  • [7] Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer
    Brown, RW
    Allred, DC
    Clark, GM
    Osborne, CK
    Hilsenbeck, SG
    CLINICAL CANCER RESEARCH, 1996, 2 (03) : 585 - 592
  • [8] The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting
    Wong, SWJ
    Rangan, AM
    Bilous, AM
    Boyages, J
    Gebski, V
    Benson, EM
    PATHOLOGY, 1999, 31 (02) : 90 - 94
  • [9] Multivariate analyses of flow cytometric S-phase and ploidy as node-negative breast cancer prognostic factors:: an international and multi-center study.
    Bagwell, CB
    Clark, GM
    Spyratos, F
    Chassevent, A
    Bendahl, PO
    Stål, O
    Killander, D
    Jourdan, ML
    Romain, S
    Hunsberger, CB
    Wright, S
    Baldetorp, B
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 260 - 260
  • [10] Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: A retrospective multicenter study
    Romain, S
    Spyratos, F
    Descotes, F
    Daver, A
    Rostaing-Puissant, B
    Bougnoux, P
    Colonna, M
    Bolla, M
    Martin, PM
    INTERNATIONAL JOURNAL OF CANCER, 2000, 87 (06) : 860 - 868